Login

• ..
• 150710 2AM-MEL---- EC Letter to NWB on WL App v3-ILAE.pdf
• 150713 2AM-MEL---- AANDC COMPLETENESS REVIEW-ILAE.PDF
• 150714 2AM-MEL---- KIA request Extension-IMLE.pdf
• 150721 2AM-MEL---- KIA Comments-ILAE.pdf
• 150721 2AM-MEL---- M150721 J150077 Meliadine WL Completeness Review-ILAE.pdf
• 150721 2AM-MEL---- UPDATED AANDC COMMENTS-ILAE.PDF
• 150723 2AM-MEL---- Additional Information-ILAE.pdf
• 150724 2AM-MEL---- Response AANDC completeness review-ILAE.pdf
• 150724 2AM-MEL---- Response KIA completeness review-ILAE.pdf
• 150730 2AM-MEL---- re Correspondence intervenor response-ILAE.pdf
• 150904 2AM-MEL---- Extension Request on Meliadine-ILAE.pdf
• 150910 2AM-MEL---- Applicant Response to Extension Request-ILAE.pdf
• 151005 2AM-MEL---- AANDC Technical Review Comments-IAAE.PDF
• 151005 2AM-MEL---- EC Tech review to NWB for Type A WL App-ILAE.pdf
• 151005 2AM-MEL---- EC Tech review to NWB for Type A WL App-table-ILAE.pdf
• 151005 2AM-MEL---- KIA cover letter final report-ILAE.pdf
• 151005 2AM-MEL---- R151002 J150077 KIA Technical Review FINAL-ILAE.pdf
• 151006 2AM-MEL---- AANDC REVIEW-CLOSURE COST ESTIMATE-ILAE.PDF
• 151009 2AM-MEL---- AANDC INDEPENDENT CLOSURE COST ESTIMATE USING RECLAIM-ILAE.PDF
• 151127 2AM-MEL---- 11 HCAA CA7 00014 DFO Letter to AEM re Review of Offsetting Plan and Mtg Summary-IAAE.pdf
• 151130 2AM-MEL---- 11-HCAA-CA7-00014 DFO Letter re Meliadine Type A Licence Public Hearing-ILAE.pdf
• 151130 2AM-MEL---- 11-HCAA-CA7-00014 DFO Letter to AEM re Review of Offsetting Plan and Mtg Summary-ILAE.pdf
• 151218 2AM-MEL---- AEM Pre-hearing conference commitments 20-21 and 22-IMLE.pdf